Stockreport

Exelixis, Inc. (EXEL) Sees Mixed Analyst Actions as Zanzalintinib Nears Commercial Launch [Yahoo! Finance]

Morgan Stanley  (MS) 
Last morgan stanley earnings: 4/16 07:15 am Check Earnings Report
US:NYSE Investor Relations: morganstanley.com/about-us-ir
PDF TheFly reported on January 8 that H.C. Wainwright analyst Robert Burns raised his price target on EXEL to $52 from $49 while maintaining a Buy rating after the company [Read more]